Cited by 62Neuroscience and Neural EngineeringRetinal Development and DisordersPhotoreceptor and optogenetics research

POLYRETINA restores light responses in vivo in blind Göttingen minipigs

Open access
Vagni, Paola, Airaghi Leccardi, Marta Jole Ildelfonsa, Vila, Charles-Henri, Zollinger, Elodie Geneviève, Sherafatipour, Golnaz, Wolfensberger, Thomas J., Ghezzi, Diego·2022·Nature Communications

Abstract

Retinal prostheses hold the potential for artificial vision in blind people affected by incurable diseases of the outer retinal layer. Available technologies provide only a small field of view: a significant limitation for totally blind people. To overcome this problem, we recently proposed a large and high-density photovoltaic epiretinal device, known as POLYRETINA. Here, we report the in vivo assessment of POLYRETINA. First, we characterise a model of chemically-induced blindness in Göttingen minipigs. Then, we develop and test a minimally invasive injection procedure to insert the large epiretinal implant into the eye. Last, we show that POLYRETINA restores light-evoked cortical responses in blind animals at safe irradiance levels. These results indicate that POLYRETINA holds the potential for artificial vision in totally blind patients affected by retinitis pigmentosa.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-31180-z

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • POLYRETINA is a high-density wide-field epiretinal prosthesis containing 10,498 photovoltaic pixels distributed over an active area of approximately 43°.

    “POLYRETINA is a high-density wide-field epiretinal prosthesis containing 10 498 photovoltaic pixels distributed over an active area of approximately 43 • [38,39,131,132].”
  • POLYRETINA is a foldable and injectable photovoltaic epiretinal prosthesis that can be safely delivered with a 6 mm size cut through the sclera and conform better to the curvature of the eye.

    “To overcome this issue, POLYRETINA is a foldable and injectable photovoltaic epiretinal prosthesis that can be safely delivered with a 6 mm size cut through the sclera and conform better to the curvature of the eye [39,38].”
  • New developments in organic bioelectronics and photovoltaics showed superior features in conformability, flexibility and stretchability compared to silicon-based technology.

    “In particular, new developments in organic bioelectronics and photovoltaics showed superior features in conformability, flexibility and stretchability [38,39] compared to silicon-based technology.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 42 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Vagni, P., Airaghi Leccardi, M. J. I., Vila, C.-H., Zollinger, E. G., Sherafatipour, G., Wolfensberger, T. J., & Ghezzi, D.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • Hôpital Ophtalmique Jules-Gonin (CH)
Corresponding author
Ghezzi, Diego
Venue
Nature Communications
Published
2022-06-27
Volume
13
Issue
1
Pages
3678-3678
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4283584388
Cited by
62
References
42
Citations by year
2026: 10 · 2025: 19 · 2024: 17 · 2023: 13 · 2022: 3
FWCI
5.75
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • Velux Stiftung (1102)
  • Gebert Rüf Stiftung (GRS-035/17)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Photoreceptor and optogenetics research
Keywords
retinal prosthesis, epiretinal implants, retinitis pigmentosa, Göttingen minipig, vision restoration, artificial vision
MeSH terms
Animals, Blindness, Humans, Retinitis Pigmentosa, Swine, Swine, Miniature, Visually Impaired Persons, Persons with Visual Disabilities, Visual Prosthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review